RETRACTED ARTICLE: Mahanine synergistically enhances cytotoxicity of 5-fluorouracil through ROS-mediated activation of PTEN and p53/p73 in colon carcinoma (Apoptosis, (2014), 19, 1, (149-164), 10.1007/s10495-013-0907-6);Mahanine synergistically enhances cytotoxicity of 5-fluorouracil through ROS-mediated activation of PTEN and p53/p73 in colon carcinoma

Apoptosis

Volumn 19, Issue 1, 2014, Pages 149-164

  Das, Ranjita ^a   Bhattacharya, Kaushik ^a   Sarkar, Sayantani ^a   Samanta, Suman Kumar ^a   Pal, Bikas C ^b   Mandal, Chitra ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

Author keywords

5 Fluorouracil; Colon cancer; Mahanine; P53; P73; PTEN

Indexed keywords

ALKALOID DERIVATIVE; FLUOROURACIL; MAHANINE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; PROTEIN P73; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL VIABILITY; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARBAZOLES; CARCINOMA; CELL LINE, TUMOR; COLONIC NEOPLASMS; DNA-BINDING PROTEINS; DRUG COMBINATIONS; DRUG SYNERGISM; FLUOROURACIL; HUMANS; MURRAYA; NUCLEAR PROTEINS; PLANT EXTRACTS; PTEN PHOSPHOHYDROLASE; REACTIVE OXYGEN SPECIES; RUTACEAE; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84892739652     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-024-01951-8     Document Type: Erratum

References (50)

1. Haggar Fatima A, Boushey Robin P (2009) Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 22(4):191-197
2. Westra JL, Plukker JT, Buys CH, Hofstra RM (2004) Genetic alterations in locally advanced stage II/III colon cancer: a search for prognostic markers. Clin Colorectal Cancer 4(4):252-259
3. Söreide K, Janssen EA, Söiland H, Körner H, Baak JP (2006) Microsatellite instability in colorectal cancer. Br J Surg 93:395-406
4. Harms K, Nozell S, Chen X (2004) The common and distinct target genes of the p53 family transcription factors. Cell Mol Life Sci 61(7-8):822-842
5. Zawacka-Pankau J, Kostecka A, Sznarkowska A, Hedström E, Kawiak A (2010) p73 tumor suppressor protein A close relative of p53 not only in structure but also in anti-cancer approach? Cell Cycle 9(4):720-728
6. Yin Y, Shen WH (2008) PTEN: a new guardian of the genome. Oncogene 27(41):5443-5453
7. Li XH, Zheng HC, Takahashi H, Masuda S, Yang XH, Takano Y (2009) PTEN expression and mutation in colorectal carcinomas. Oncol Rep 22(4):757-764
8. de la Cruz-Morcillo MA, Valero ML, Callejas-Valera JL, Arias- González L, Melgar-Rojas P, Galán-Moya EM, Garcia-Gil E, Garcia-Cano J, Sánchez-Prieto R (2012) p38MAPK is a major determinant of the balance between apoptosis and autophagy triggered by 5-fluorouracil: implication in resistance. Oncogene 31(9):1073-1085
9. Ruzzo A, Graziano F, Loupakis F, Santini D, Catalano V, Bisonni R, Ficarelli R, Fontana A, Andreoni F, Falcone A, Canestrari E, Tonini G, Mari D, Lippe P, Pizzagalli F, Schiavon G, Alessandroni P, Giustini L, Maltese P, Testa E, Menichetti ET, Magnani M (2008) Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy. Pharmacogenomics J 8:278-288
10. Sinicrope FA, Sargent DJ (2012) Molecular pathways: microsatellite instability in colorectal cancer: prognostic, predictive, and therapeutic implications. Clin Cancer Res 18(6):1506-1512
11. Kodach LL, Bos CL, Durán N, Peppelenbosch MP, Ferreira CV, Hardwick JC (2006) Violacein synergistically increases 5-fluorouracil cytotoxicity, induces apoptosis and inhibits Akt-mediated signal transduction in human colorectal cancer cells. Carcinogenesis 27(3):508-516
12. Ramsewak RS, Nair MG, Strasburg GM, DeWitt DL, Nitiss JL (1999) Biologically active carbazole alkaloids from Murraya koenigii. J Agric Food Chem 47:444-447
13. Nakahara K, Trakoontivakorn G, Alzoreky NS, Ono H, Onishi- Kameyama M, Yoshida M (2002) Antimutagenicity of some edible Thai plants, and a bioactive carbazole alkaloid, mahanine, isolated from Micromelum minsutum. J Agric Food Chem 50:4796-4802
14. Ito C, Itoigawa M, Nakao K, Murata T, Tsuboi M, Kaneda N et al (2006) Induction of apoptosis by carbazole alkaloids isolated from Murraya koenigii. Phytomedicine 13:359-365
15. Roy MK, Thalang VN, Trakoontivakorn G, Nakahara K (2004) Mechanism of mahanine-induced apoptosis in human leukemia cells (HL-60). Biochem Pharmacol 67:41-51
16. Sinha S, Pal BC, Jagadeesh S, Banerjee PP, Bandyopadhaya A, Bhattacharya S (2006) Mahanine inhibits growth and induces apoptosis in prostate cancer cells through the deactivation of Akt and activation of caspases. Prostate 66:1257-1265
17. Roy MK, Thalang VN, Trakoontivakorn G, Nakahara K (2005) Mahanine, a carbazole alkaloid from Micromelum minutum, inhibits cell growth and induces apoptosis in U937 cells through a mitochondrial dependent pathway. Br J Pharmacol 145:145-155
18. Bhattacharya K, Samanta SK, Tripathi R, Mallick A, Chandra S, Pal BC, Shaha C, Mandal C (2010) Apoptotic effects of mahanine on human leukemic cells are mediated through crosstalk between Apo-1/Fas signaling and the Bid protein and via mitochondrial pathways. Biochem Pharmacol 79:361-372
19. Sarkar S, Dutta D, Samanta SK, Bhattacharya K, Pal BC, Li J, Datta K, Mandal C, Mandal C (2013) Oxidative inhibition of Hsp90 disrupts the super-chaperone complex and attenuates pancreatic adenocarcinoma in vitro and in vivo. Int J Cancer 132(3):695-706
20. Samanta SK, Dutta D, Roy S, Bhattacharya K, Sarkar S, Dasgupta AK, Pal BC, Mandal C, Mandal C. (2013) Mahanine, A DNA Minor Groove Binding Agent Exerts Cellular Cytotoxicity with Involvement of C-7-OH and -NH Functional Groups. J Med Chem. PMID: 23829449
21. Jagadeesh S, Sinha S, Pal BC, Bhattacharya S, Banerjee PP (2007) Mahanine reverses an epigenetically silenced tumor suppressor gene RASSF1A in human prostate cancer cells. Biochem Biophys Res Commun 362:212-217
22. Chou TC (2006) Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 58:621-681
23. Mandal C, Dutta A, Mallick A, Chandra S, Misra L, Sangwan RS et al (2008) Withaferin A induces apoptosis by activating p38 mitogen-Activated protein kinase signaling cascade in leukemic cells of lymphoid and myeloid origin through mitochondrial death cascade. Apoptosis 13:1450-1464
24. Alter P, Herzum M, Soufi M, Schaefer JR, Maisch B (2006) Cardiotoxicity of 5-fluorouracil. Cardiovasc Hematol Agents Med Chem 4(1):1-5
25. Chang CT, Ho TY, Lin H, Liang JA, Huang HC, Li CC, Lo HY, Wu SL, Huang YF, Hsiang CY (2012) 5-Fluorouracil induced intestinal mucositis via nuclear factor-jB activation by transcriptomic analysis and in vivo bioluminescence imaging. Plos One 7(3):e31808
26. De Angelis PM, Svendsrud DH, Kravik KL, Stokke T (2006) Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery. Mol Cancer 5:20
27. Torigoe S, Ogata Y, Matono K, Shirouzu K (2009) Molecular mechanisms of sequence-dependent antitumor effects of SN-38 and 5-fluorouracil combination therapy against colon cancer cells. Anticancer Res 29(6):2083-2089
28. Tophkhane C, Yang SH, Jiang Y, Ma Z, Subramaniam D, Anant S, Yogosawa S, Sakai T, Liu WG, Edgerton S, Thor A, Yang X (2012) p53 inactivation upregulates p73 expression through E2F- 1 mediated transcription. Plos One 7(8):e43564
29. Chang CJ, Mulholland DJ, Valamehr B, Mosessian S, Sellers WR, Wu H (2008) PTEN nuclear localization is regulated by oxidative stress and mediates p53-dependent tumor suppression. Mol Cell Biol 28(10):3281-3289
30. Planchon SM, Waite KA, Eng C (2008) The nuclear affairs of PTEN. J Cell Sci 121:249-253
31. Michael D, Oren M (2002) The p53 and Mdm2 families in cancer. Curr Opin Genet Dev 12(1):53-59
32. Lau LM, Nugent JK, Zhao X, Irwin MS (2008) HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function. Oncogene 27(7):997-1003
33. Zhang N, Yin Y, Xu SJ, Chen WS (2008) 5-Fluorouracil: mechanisms of resistance and reversal strategies. Molecules 13(8):1551-1569
34. Vilgelm AE, WashingtonMK,Wei J, Chen H, Prassolov VS, Zaika AI (2010) Interactions of the p53 protein family in cellular stress response in gastrointestinal tumors. Mol Cancer Ther 9(3):693-705
35. Sasaki Y, Koyama R, Maruyama R, Hirano T, Tamura M, Sugisaka J, Suzuki H, Idogawa M, Shinomura Y, Tokino T (2012) CLCA2, a target of the p53 family, negatively regulates cancer cell migration and invasion. Cancer Biol Ther 13(14):1512-1521
36. Sankpal NV, Willman MW, Fleming TP, Mayfield JD, Gillanders WE (2009) Transcriptional repression of epithelial cell adhesion molecule contributes to p53 control of breast cancer invasion. Cancer Res 69(3):753-757
37. Mandal C, Pal BC, Bhattacharya K, Samanta SK, Sarkar S and Das R (2013) Process for the isolation of organic compounds useful for the treatment of cancer. US Patent 2013/0065932 A1 Pub. date, March 14
38. HemaIswarya S, Doble M (2006) Potential synergism of natural products in the treatment of cancer. Phytother Res. 20(4):239-249
39. Santandreu FM, Valle A, Oliver J, Roca P (2011) Resveratrol potentiates the cytotoxic oxidative stress induced by chemotherapy in human colon cancer cells. Cell Physiol Biochem 28(2):219-228
40. Hwang JT, Ha J, Park OJ (2005) Combination of 5-fluorouracil and genistein induces apoptosis synergistically in chemo-resistant cancer cells through the modulation of AMPK and COX-2 signaling pathways. Biochem Biophys Res Commun 332(2):433-440
41. Wang CZ, Luo X, Zhang B, Song WX, Ni M, Mehendale S, Xie JT, Aung HH, He TC, Yuan CS (2007) Notoginseng enhances anti-cancer effect of 5-fluorouracil on human colorectal cancer cells. Cancer Chemother Pharmacol 60(1):69-79
42. Jin HR, Zhao J, Zhang Z, Liao Y, Wang CZ, Huang WH, Li SP, He TC, Yuan CS, Du W (2012) The antitumor natural compound falcarindiol promotes cancer cell death by inducing endoplasmic reticulum stress. Cell Death Dis 3:e376
43. Lai D, Visser-Grieve S, Yang X (2012) Tumour suppressor genes in chemotherapeutic drug response. Biosci Rep 32(4):361-374
44. Song MS, Song SJ, Kim SY, Oh HJ, Lim DS (2008) The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complex. EMBO J 27(13):1863-1874
45. Kodiha M, Stochaj U (2012) Nuclear transport: a switch for the oxidative stress-signaling circuit? J Signal Transduct 2012:208650
46. Lehman JA, Waning DL, Batuello CN, Cipriano R, Kadakia MP, Mayo LD (2011) Induction of apoptotic genes by a p73-phosphatase and tensin homolog (p73-PTEN) protein complex in response to genotoxic stress. J Biol Chem 286(42):36631-36640
47. Rahal OM, Simmen RC (2010) PTEN and p53 cross-regulation induced by soy isoflavone genistein promotes mammary epithelial cell cycle arrest and lobuloalveolar differentiation. Carcinogenesis 31(8):1491-1500
48. Hwang IT, Chung YM, Kim JJ, Chung JS, Kim BS, Kim HJ, Kim JS, Yoo YD (2007) Drug resistance to 5-FU linked to reactive oxygen species modulator 1. Biochem Biophys Res Commun 359(2):304-310
49. Hwang PM, Bunz F, Yu J, Rago C, Chan TA, Murphy MP, Kelso GF, Smith RA, Kinzler KW, Vogelstein B (2001) Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells. Nat Med 7(10):1111-1117
50. Katara R, Singh N (2008) Role of p53 in transcriptional regulation of proteases in mammals. Ind J Med Paediatr Oncol 29(4):19-22